KRTAP13-4 inhibitors represent a class of chemical compounds that target the keratin-associated protein 13-4 (KRTAP13-4). KRTAP proteins are structural components involved in the regulation of keratin fibers, essential elements in the formation of hair and nails. KRTAP13-4, in particular, is part of a family of proteins that interact with keratin intermediate filaments, influencing their stability, assembly, and structural integrity. Inhibitors of KRTAP13-4 are designed to modulate this interaction by selectively binding to or modifying KRTAP13-4, thereby affecting the structural dynamics of keratin filaments. These compounds may disrupt or alter keratin fiber formation and stability by interfering with the role of KRTAP13-4 in keratin filament organization.
Chemically, KRTAP13-4 inhibitors can belong to various classes, including small molecules, peptides, or larger biomolecules. Their mechanisms of action may involve direct binding to the KRTAP13-4 protein to block its interaction with keratin or other associated proteins, or they may indirectly alter its activity through modulation of upstream or downstream signaling pathways involved in keratin regulation. Structurally, these inhibitors can feature diverse functional groups that allow for specific binding to key active sites on the KRTAP13-4 protein. This selectivity is essential for ensuring that the inhibitors affect the targeted protein without causing widespread disruption to other keratin-associated proteins or cellular functions. The development and characterization of KRTAP13-4 inhibitors require a detailed understanding of the protein's structure and its binding partners to design compounds that are both effective and specific in their action.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could induce hypomethylation of the KRTAP13-4 gene promoter, leading to chromatin remodeling that silences gene expression, thereby decreasing KRTAP13-4 levels. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A might loosen chromatin structure by inhibiting histone deacetylase, which could lower transcriptional activity of the KRTAP13-4 gene. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea could stall the DNA replication fork progress, potentially leading to a reduction in KRTAP13-4 mRNA synthesis due to a compromised DNA template. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D might intercalate into the KRTAP13-4 gene, obstructing RNA polymerase movement, thereby curtailing KRTAP13-4 mRNA transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin could specifically inhibit RNA polymerase II, sharply curtailing the transcription of KRTAP13-4 and subsequent protein synthesis. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may bind to its nuclear receptors and alter the transcriptional machinery, leading to a decreased expression of hair follicle-related genes like KRTAP13-4. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By inhibiting mTOR signaling, Rapamycin could suppress the initiation of cap-dependent translation, resulting in reduced synthesis of proteins including KRTAP13-4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 could inhibit PI3K, leading to a downregulation of the AKT signaling pathway and potentially reducing the transcription of downstream genes such as KRTAP13-4. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A might bind to specific DNA sequences upstream of the KRTAP13-4 gene, preventing the binding of transcription factors required for its expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
By blocking the translocation step in protein synthesis, Cycloheximide could lead to a general decrease in protein levels, including the downregulation of KRTAP13-4. | ||||||